A phase 1 study of ruxolitinib, steroids and lenalidomide for relapsed/refractory multiple myeloma patients
Year: 2022
Type: article
Study design: Clinical Trial
Source: Hematological Oncology
DOI: 10.1002/hon.3066
Authors: James R. Berenson, Clara Kim, Sean Bujarski, Jennifer To, Tanya M. Spektor, Daisy Martinez, Carley Turner, Matthew Ghermezi, Benjamin M. Eades, Regina A. Swift, Gary Schwartz, Shahrooz Eshaghian, Robert A. Moss, Stephen Lim, Robert Vescio
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Incyte
OpenAlex ID: W4291397341